This study is looking at how two different insulin treatments affect blood sugar levels after meals in pregnant women with gestational diabetes (GDM). You would be between 18 and 40 years old, have a single pregnancy between 24-34 weeks, and currently use injected rapid-acting insulin analog (RAA) for breakfast. The study compares your usual RAA injections to an inhaled insulin called Technosphere Insulin (Afrezza). You'll come to the clinic for two meal sessions. For one meal, you'll use RAA, and for the other, you'll use Afrezza. The main goal is to see which insulin better controls your blood sugar for up to two hours after eating. The study aims to enroll 30 participants, but its current status is unclear.

Study design

This is an interventional study comparing two insulin treatments in 30 pregnant women. Participants will be randomly assigned to receive either inhaled Technosphere Insulin (Afrezza) or rapid-acting insulin analog (RAA) for their first study meal, then switch to the other for their second meal.

What's involved

You would attend two clinic visits for meal sessions, where your blood sugar levels will be monitored after eating.

Compensation

Not stated in the trial record.

Follow-up

Blood sugar levels will be measured for up to 120 minutes (2 hours) after each meal.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.